Reducing Delays to Antiretroviral (ARV) Receipt in Children Prescribed Post-Exposure Prophylaxis (PEP) for HIV: Meds-in-Hand and a Multidisciplinary Team Approach

摘要

BackgroundProvision of antiretrovirals (ARVs) for pediatric patients who require HIV post-exposure prophylaxis (PEP) poses many challenges. Many pharmacies do not stock pediatric formulations of ARVs. Prior authorizations and misunderstanding of medication quantity and urgency can delay filling and result in treatment interruptions, risking PEP’s efficacy. While 3-day starter packs are standard of care for patients prescribed PEP in the Emergency Department (ED), we are not aware of programs designed to ensure pediatric patients receive the full 28-day course.